ArticleScientific reports2026
Elevated blood viscosity in thyroid-associated ophthalmopathy and its association with thyroid-stimulating immunoglobulin levels.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Elevated blood viscosity (BV) is a key factor in vascular diseases; however, its role in thyroid-associated ophthalmopathy (TAO) and its association with autoimmune activity remain unclear. This study examined the relationship between BV, thyroid-stimulating immunoglobulin (TSI) levels, and clinical parameters in TAO. Specifically, we measured the systolic BV (SBV) and diastolic BV (DBV) of 70 patients with TAO and 48 controls using a scanning capillary tube viscometer and examined the correlation between BV and clinical and laboratory markers. Patients with TAO were stratified according to the median BV to assess the differences in TSI and thyroid function markers. Patients with TAO had significantly higher median SBV (p = 0.028) and DBV (p = 0.006) than those in the control group. BV correlated positively with TSI (rho = 0.241, p = 0.044 for SBV; rho = 0.239, p = 0.046 for DBV). T3 showed a weak positive correlation in univariable analysis; however, in multivariable analy`sis, only TSI remained significantly associated with SBV (p = 0.019) and DBV (p = 0.015). TAO was associated with elevated systemic BV, likely related to autoimmune activity and largely explained by hematologic parameters. These findings highlight the interplay between autoimmunity, hematology, and blood rheology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.